What Is Lymphoma? Adolescent and Young Adult Lymphoma › Chronic Lymphocytic Leukemia › Hodgkin Lymphoma › Non-Hodgkin Lymphoma › LEARN MORE
What resources are available? Fact Sheets and Guides › Education Programs › LRF Helpline › Lymphoma Support Network › Mobile App › LEARN MORE
What can I do to help? Accelerate Lymphoma Research › Attend an Event › Become an Advocate › Join Team LRF – Walks, Ride, DIY › Volunteer as a buddy › Ways to Give › LEARN MORE
EVERY 5 MINUTES SOMEONE IN THE U.S. IS DIAGNOSED WITH LYMPHOMA. Learn more about our impact $62 MILLION LRF HAS FUNDED MORE THAN Learn more about our impact on research IN LYMPHOMA-SPECIFIC RESEARCH 10,000 LRF’S TRAINED SOCIAL WORKERS PROVIDE INDIVIDUAL SUPPORT AND INFORMATION TO NEARLY Contact the LRF Helpline PATIENTS EACH YEAR Accelerate the pace of lymphoma research. $ Accelerate the pace of lymphoma research. $ STORIES OF HOPE View all › BRUCE, DLBCL SURVIVOR › “I met so many survivors who've inspired me.” GIULIANA, HL SURVIVOR › “I find joy in connecting with patients to remind them that you are not alone.” BARRY, CLL SURVIVOR › "The more you learn about the disease the less fearful you are about it." CHRIS, PTCL CAREGIVER › "My advice to caregivers is to let others know what you’re going through so they can offer their support."
Research News Meet the 2020 Lymphoma Clinical Mentoring Program Scholars 6/17/2020 The new class of LRF Scholars is pursuing research projects covering a diverse range of lymphoma subtypes with a goal to improve patient outcomes.
Lymphoma News U.S. Food and Drug Administration Approves Selinexor (XPOVIO) for Diffuse Large B-cell Lymphoma
